English
Home > Products > CAS NO 461-82-5

China CAS NO 461-82-5 Factory

"Control the quality by the details, show the strength by quality". Our company has strived to establish a highly efficient and stable staff team and explored an effective quality control process for CAS NO 461-82-5,461-82-5,4-(Trifluoromethoxy)aniline, We sincerely welcome buddies to negotiate business enterprise and start cooperation with us. We hope to join hands with good friends in different industries to produce a brilliant long term.
CAS NO 461-82-5, Our tenet is "integrity first, quality best". We've got confidence in providing you with excellent service and ideal solutions. We sincerely hope we can establish win-win business cooperation with you in the future!

Related Products

Hot Products

  • 7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid

    7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid

    Product Name:7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
    Molecular Formula:C13H9ClFNO3
    Molecular Weight:281.67
    CAS Registry Number:86393-33-1
  • Memantine HC

    Memantine HC

    Product Name:Memantine HC
    Molecular Formula:C12H22ClN
    Molecular Weight;215.76
    CAS Registry Number;41100-52-1
  • Bicalutamide

    Bicalutamide

    Product Name:Bicalutamide
    Molecular Formula:C18H14F4N2O4S
    Molecular Weight;430.37
    CAS Registry Number;90357-06-5
  • Dabrafenib

    Dabrafenib

    Product Name:Dabrafenib
    Molecular Formula:C23H20F3N5O2S2
    Molecular Weight;519.56
    CAS Registry Number;1195765-45-7
  • 2,3-Difluorobenzoic acid

    2,3-Difluorobenzoic acid

    Product Name:2,3-Difluorobenzoic acid
    Molecular Formula:C7H4F2O2
    Molecular Weight:158.1
    CAS Registry Number:4519-39-5
  • 5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic acid

    5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic acid

    Product Name:5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic acid
    Molecular Formula:C10H9N3O3
    Molecular Weight:219.19676
    CAS Registry Number:1293284-55-5
  • Related Blog
  • Reviews

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept